Literature DB >> 26348417

Oxygen extraction and perfusion markers in severe sepsis and septic shock: diagnostic, therapeutic and outcome implications.

Emanuel P Rivers1, Angel Coz Yataco, Anja Kathrina Jaehne, Jasreen Gill, Margaret Disselkamp.   

Abstract

PURPOSE OF REVIEW: The purpose of this study is to review the recent literature examining the clinical utility of markers of systemic oxygen extraction and perfusion in the diagnosis, treatment and prognosis of severe sepsis and septic shock. RECENT
FINDINGS: When sepsis is accompanied by conditions in which systemic oxygen delivery does not meet tissue oxygen demands, tissue hypoperfusion begins. Tissue hypoperfusion leads to oxygen debt, cellular injury, organ dysfunction and death. Tissue hypoperfusion can be characterized using markers of tissue perfusion (central venous oxygen saturation and lactate), which reflect the interaction between systemic oxygen delivery and demands. For the last two decades, studies and quality initiatives incorporating the early detection and interruption of tissue hypoperfusion have been shown to improve mortality and altered sepsis care. Three recent trials, while confirming an all-time improvement in sepsis mortality, challenged the concept that rapid normalization of markers of perfusion confers outcome benefit. By defining and comparing haemodynamic phenotypes using markers of tissue perfusion, we may better understand which patients are more likely to benefit from early goal-directed haemodynamic optimization.
SUMMARY: The phenotypic haemodynamic characterization of patients using perfusion markers has diagnostic, therapeutic and outcome implications in severe sepsis and septic shock. However, irrespective of haemodynamic phenotype, the outcome reflects the quality of care provided at the point of presentation. Utilizing these principles may allow more objective interpretation of resuscitation trials and translate these findings into current practice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26348417     DOI: 10.1097/MCC.0000000000000241

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  9 in total

1.  Continual hemodynamic monitoring with a single-use transesophageal echocardiography probe in critically ill patients with shock: a randomized controlled clinical trial.

Authors:  Tobias M Merz; Luca Cioccari; Pascal M Frey; Andreas Bloch; David Berger; Bjoern Zante; Stephan M Jakob; Jukka Takala
Journal:  Intensive Care Med       Date:  2019-07-04       Impact factor: 17.440

2.  Central venous oxygen saturation/lactate ratio: a novel predictor of outcome following emergency open laparotomy.

Authors:  Gomaa Salem; Nora Ismail Abbas; Ahmed Yehia Zakaria; Wahid Ahmed Radwan
Journal:  Eur J Trauma Emerg Surg       Date:  2019-07-17       Impact factor: 3.693

3.  Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial.

Authors:  Xiao-Jin Li; Ru-Rong Wang; Yan Kang; Jin Liu; Yun-Xia Zuo; Xue-Feng Zeng; Gong Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-18       Impact factor: 2.629

Review 4.  Early Liberal Fluid Therapy for Sepsis Patients Is Not Harmful: Hydrophobia Is Unwarranted but Drink Responsibly.

Authors:  Anja K Jaehne; Emanuel P Rivers
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

Review 5.  Approach of minimal invasive monitoring and initial treatment of the septic patient in emergency medicine.

Authors:  German Devia Jaramillo; Jenny Castro Canoa; Emiro Valverde Galván
Journal:  Open Access Emerg Med       Date:  2018-11-20

6.  A Novel Cross-Linked Hemoglobin-Based Oxygen Carrier, YQ23, Extended the Golden Hour for Uncontrolled Hemorrhagic Shock in Rats and Miniature Pigs.

Authors:  Lei Kuang; Yu Zhu; Yue Wu; Kunlun Tian; Xiaoyong Peng; Mingying Xue; Xinming Xiang; Billy Lau; Fei Chuen Tzang; Liangming Liu; Tao Li
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

7.  Absent Metabolic Transition from the Early to the Late Period in Non-Survivors Post Cardiac Surgery.

Authors:  Cecilia Veraar; Arabella Fischer; Martin H Bernardi; Isabella Sulz; Mohamed Mouhieddine; Martin Dworschak; Edda Tschernko; Andrea Lassnigg; Michael Hiesmayr
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

8.  Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial.

Authors:  Akira Endo; Kazuma Yamakawa; Takashi Tagami; Yutaka Umemura; Kyosuke Takahashi; Hiroki Nagasawa; Yuichi Araki; Mitsuaki Kojima; Toshiki Sera; Masayuki Yagi; Ryo Yamamoto; Jiro Takahashi; Masaki Nakane; Chikashi Takeda; Chihiro Narita; Satoshi Kazuma; Hiroko Okura; Hiroyuki Takahashi; Takeshi Wada; Shu Tahara; Ayaka Matsuoka; Todani Masaki; Atsushi Shiraishi; Keiichiro Shimoyama; Yuta Yokokawa; Rintaro Nakamura; Hisako Sageshima; Yuichiro Yanagida; Kunihiko Takahashi; Yasuhiro Otomo
Journal:  Trials       Date:  2022-09-24       Impact factor: 2.728

Review 9.  Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE.

Authors:  H Bryant Nguyen; Anja Kathrin Jaehne; Namita Jayaprakash; Matthew W Semler; Sara Hegab; Angel Coz Yataco; Geneva Tatem; Dhafer Salem; Steven Moore; Kamran Boka; Jasreen Kaur Gill; Jayna Gardner-Gray; Jacqueline Pflaum; Juan Pablo Domecq; Gina Hurst; Justin B Belsky; Raymond Fowkes; Ronald B Elkin; Steven Q Simpson; Jay L Falk; Daniel J Singer; Emanuel P Rivers
Journal:  Crit Care       Date:  2016-07-01       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.